Dalius J. Briedis, McGill University
Associate Professor
Microbiology and Immunology
Montreal, Quebec
dalius.briedis@mcgill.ca
Office:
(514) 398-3925
Expert In
Bio/Research
Despite the development of an apparently effective vaccine against measles in the early 1960's, it remains the number one infectious killer in the developing world. The disease strikes about 44 million children a year and kills 1.5 million of them. Moreover, in the 1980s and '90s, large scale out...
Click to Expand >>
Click to Expand >>
Bio/Research
Despite the development of an apparently effective vaccine against measles in the early 1960's, it remains the number one infectious killer in the developing world. The disease strikes about 44 million children a year and kills 1.5 million of them. Moreover, in the 1980s and '90s, large scale outbreaks of measles have occurred 3 out of 4 years in North America.
Really effective control of measles will likely require development of a genetically-engineered vaccine that contains protective viral elements with none of the components that can cause immunosuppression. Existing basic knowledge of what happens during measles virus infection is currently inadequate for such a task. My laboratory is currently one of only a handful worldwide conducting intensive research into the molecular biology and immunology of measles virus infection and replication.
Click to Shrink <<
Really effective control of measles will likely require development of a genetically-engineered vaccine that contains protective viral elements with none of the components that can cause immunosuppression. Existing basic knowledge of what happens during measles virus infection is currently inadequate for such a task. My laboratory is currently one of only a handful worldwide conducting intensive research into the molecular biology and immunology of measles virus infection and replication.
Click to Shrink <<